Cargando…

Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia

Spontaneous adverse drug reactions (ADRs) reporting is a useful source of drug safety information in infants as only adult patients are routinely tested in clinical trials. This study was aimed to evaluate the spontaneously reported ADRs using WHO Adverse Reaction Terminology and to identify the com...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosli, Rosliana, Dali, Ahmad Fauzi, Aziz, Noorizan Abd., Ming, Long Chiau, Manan, Mohamed Mansor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300992/
https://www.ncbi.nlm.nih.gov/pubmed/28239351
http://dx.doi.org/10.3389/fphar.2017.00030
_version_ 1782506277911396352
author Rosli, Rosliana
Dali, Ahmad Fauzi
Aziz, Noorizan Abd.
Ming, Long Chiau
Manan, Mohamed Mansor
author_facet Rosli, Rosliana
Dali, Ahmad Fauzi
Aziz, Noorizan Abd.
Ming, Long Chiau
Manan, Mohamed Mansor
author_sort Rosli, Rosliana
collection PubMed
description Spontaneous adverse drug reactions (ADRs) reporting is a useful source of drug safety information in infants as only adult patients are routinely tested in clinical trials. This study was aimed to evaluate the spontaneously reported ADRs using WHO Adverse Reaction Terminology and to identify the common drugs associated with ADRs in children under 2 years of age. A retrospective analysis of ADR data for children below 2 years old from 2000 to 2013 was conducted using the data extracted from Malaysia’s national pharmacovigilance database, QUEST2 System. From 2000 to 2013, Malaysia’s National Pharmaceutical Control Bureau received a total of 11,932 reports for children from various healthcare facilities in Malaysia. 14.0% (n = 1667) of the ADRs reported for those children were related to children under 2 years old. The data retrieved was analyzed in terms of age, gender, source of reporting, type of reporters, suspected medicines and characteristics of ADRs (category, onset, severity, and outcomes). A total of 1312 ADRs reported in 907 ADR reports were analyzed. The most common ADRs reported were skin appendage disorders (60.1%), and the most frequently reported symptoms were rash (n = 215), maculopapular rash (n = 206), urticaria (n = 169), erythematous rash (n = 76), and pruritus (n = 58). In general, drugs from antibacterials for systemic use (58.8%) appeared to be the most common contributors to ADRs in children below 2 years old. Penicillins and other β-Lactam Antibacterials accounted for more than 40% of all drugs implicated in ADRs. The majority of ADRs were subacute reactions that occurred within 24 h of exposure to the drug. A high proportion of ADRs was classified as mild, and most victims had no sequela. Only one fatality was seen. There were 10 cases for each symptom, namely erythema multiforme and Stevens–Johnson Syndrome, observed in this study. A large proportion of ADRs in children under 2 years old were mainly caused by drugs from antibacterial for systemic use, with most of the ADRs manifesting in skin reactions. This study also reveals rare cutaneous ADRs experienced by Malaysian children under the age of 2, which constitutes a crucial cause of harm among children.
format Online
Article
Text
id pubmed-5300992
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53009922017-02-24 Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia Rosli, Rosliana Dali, Ahmad Fauzi Aziz, Noorizan Abd. Ming, Long Chiau Manan, Mohamed Mansor Front Pharmacol Pharmacology Spontaneous adverse drug reactions (ADRs) reporting is a useful source of drug safety information in infants as only adult patients are routinely tested in clinical trials. This study was aimed to evaluate the spontaneously reported ADRs using WHO Adverse Reaction Terminology and to identify the common drugs associated with ADRs in children under 2 years of age. A retrospective analysis of ADR data for children below 2 years old from 2000 to 2013 was conducted using the data extracted from Malaysia’s national pharmacovigilance database, QUEST2 System. From 2000 to 2013, Malaysia’s National Pharmaceutical Control Bureau received a total of 11,932 reports for children from various healthcare facilities in Malaysia. 14.0% (n = 1667) of the ADRs reported for those children were related to children under 2 years old. The data retrieved was analyzed in terms of age, gender, source of reporting, type of reporters, suspected medicines and characteristics of ADRs (category, onset, severity, and outcomes). A total of 1312 ADRs reported in 907 ADR reports were analyzed. The most common ADRs reported were skin appendage disorders (60.1%), and the most frequently reported symptoms were rash (n = 215), maculopapular rash (n = 206), urticaria (n = 169), erythematous rash (n = 76), and pruritus (n = 58). In general, drugs from antibacterials for systemic use (58.8%) appeared to be the most common contributors to ADRs in children below 2 years old. Penicillins and other β-Lactam Antibacterials accounted for more than 40% of all drugs implicated in ADRs. The majority of ADRs were subacute reactions that occurred within 24 h of exposure to the drug. A high proportion of ADRs was classified as mild, and most victims had no sequela. Only one fatality was seen. There were 10 cases for each symptom, namely erythema multiforme and Stevens–Johnson Syndrome, observed in this study. A large proportion of ADRs in children under 2 years old were mainly caused by drugs from antibacterial for systemic use, with most of the ADRs manifesting in skin reactions. This study also reveals rare cutaneous ADRs experienced by Malaysian children under the age of 2, which constitutes a crucial cause of harm among children. Frontiers Media S.A. 2017-02-10 /pmc/articles/PMC5300992/ /pubmed/28239351 http://dx.doi.org/10.3389/fphar.2017.00030 Text en Copyright © 2017 Rosli, Dali, Aziz, Ming and Manan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Rosli, Rosliana
Dali, Ahmad Fauzi
Aziz, Noorizan Abd.
Ming, Long Chiau
Manan, Mohamed Mansor
Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
title Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
title_full Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
title_fullStr Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
title_full_unstemmed Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
title_short Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
title_sort reported adverse drug reactions in infants: a nationwide analysis in malaysia
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300992/
https://www.ncbi.nlm.nih.gov/pubmed/28239351
http://dx.doi.org/10.3389/fphar.2017.00030
work_keys_str_mv AT roslirosliana reportedadversedrugreactionsininfantsanationwideanalysisinmalaysia
AT daliahmadfauzi reportedadversedrugreactionsininfantsanationwideanalysisinmalaysia
AT aziznoorizanabd reportedadversedrugreactionsininfantsanationwideanalysisinmalaysia
AT minglongchiau reportedadversedrugreactionsininfantsanationwideanalysisinmalaysia
AT mananmohamedmansor reportedadversedrugreactionsininfantsanationwideanalysisinmalaysia